The ACCELLIX™ Automated Flow Cytometer
Reproducible & Efficient Phenotyping for Cell Therapy Manufacturing
To demonstrate reproducibility and efficiency, Accellix, in collaboration with Triumvira, conducted a study that aims to demonstrate the ease of use, high reproducibility and comparability of the ACCELLIX™ platform to conventional cytometers and cell counters.
Summary
This data demonstrates that the ACCELLIX™ platform:
- Is able to detect with good resolution, events between the sizes of 0.95 μM—15.4 μM which includes all major cell lineages.
- Generates highly reproducible phenotyping data in different research environments for various CD-markers.
- Is insensitive to inter-operator variability, as shown by four different end-users for various CD-markers.
- Is highly comparable in cell frequencies to conventional flow cytometers, like the CytoFLEX, and with similar %CV within runs.
- Yields similar cell counts to those obtained with the NC-200 and VizBlue cell counters.
Download the Poster
Complete the form below to access the poster, which will be sent directly to your email after submission. By providing your information, you agree to receive additional emails from bioMérieux about cell therapy quality control.
To find out more about the management of your personal data and to exercise your rights, see our privacy policy.
